Navigation Links
Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
Date:4/23/2013

Winston-Salem, North Carolina (PRWEB) April 23, 2013

The Veterinary Bioscience Institute (VBI) http://www.vetbiotech.com is thrilled to announce that Jennifer C. Smith DVM, DACLAM has joined VBI full-time as Vice President of Research and Development.

As part of expansion plans for the Veterinary Bioscience Institute, hiring prominent, well-respected and highly-educated individuals to join the team is a foundation of this growth. More individuals contributing their thoughts and ideas to VBI's highly collaborative environment will ensure continued success of the company.

Dr. Smith has over 15 years of industry experience. Since 2006 she served at Taconic Inc as the Associate Director of Veterinary Services. Previous to that she served at Amgen Inc as a clinical veterinarian, culminating as the Associate Directory of Laboratory Animal Resources.

“We are growing rapidly, and we are fanatical about hiring only the best, most respected individuals to be part of the team at VBI,” states Dr. Elizabeth Johnson, CEO of the Veterinary Bioscience Institute. “Dr. Smith has a great reputation as a clinician, researcher and instructor. Her commitment to animal welfare and laboratory animal science is unwavering, and she continues to uphold the highest standards in promoting excellence across the entire profession.”

Dr. Smith will primarily be responsible for developing a world-class GLP rodent facility at the Wake Forest Innovation Quarter, and will also contribute heavily to the educational materials and workshops that VBI offers to their clients.

“VBI has quickly become an important company within the laboratory animal industry,” Dr. Smith says, “and it’s an honor to have the opportunity to build on its success”.

Dr. Szczepan Baran, President of the Veterinary Bioscience Institute thinks that this addition to the team was one that was a long time in the making, but couldn’t have come at a better time. “Now that Dr. Smith has joined us, VBI will be able to expand its course offerings and offer a state-of-the-art facility to perform studies that meet and exceed GLP requirements. We are truly fortunate to have her on the team, and know that this addition takes VBI to the next level.”

In addition to the GLP facility and course work, Dr. Smith will be preparing, presenting and participating in workshops presented by VBI at the Wake Forest Innovation Quarter at Wake Forest University in Winston-Salem, North Carolina. These workshops begin in May, and cover a variety of topics, from rodent microsurgery to complex anesthesia and analgesia cases. http://vetbiotech.com/workshops.php

The Veterinary Bioscience Institute is a member of the Wake Forest Innovation Quarter, and provides online and on-site continuing education and training for the life sciences community. VBI specializes in the art and science of surgical and biomethodology training, and aligns itself with experts in the scientific community to deliver unsurpassed education.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10656435.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Jennifer Aniston's People's Choice Awards Dress Worries Animal Welfare Advocates; Going Green News Site My Cleaning Products Comments It Was a Bad Pick
2. Law Office of Brodsky & Smith, LLC Announces Investigation of Complete Genomics, Inc.
3. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
4. Robert Farrell Joins Bionovos Board of Directors
5. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
6. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
7. First Choice Rehabilitation Specialists Joins Select Medical
8. Excel Life Sciences Joins DATATRAKs Connect Partner Program
9. Marina Biotech, Inc. Joins OTCQX
10. Richard H. Scheuermann, Ph.D. Joins J. Craig Venter Institute as Director of Informatics
11. Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016 Australian-US drug discovery ... announced today the appointment of a new Chairman, Mr ... Carmine , effective immediately. James Garner , ... Executive Director and former Acting CEO, Mr Iain Ross ... Non-Executive Director. --> James Garner , has also ...
(Date:2/4/2016)... ... 04, 2016 , ... Shimadzu Scientific Instruments will showcase several ... and poster sessions, and present on the analysis of mycotoxins and medical cannabis ... to 10 at the Georgia World Congress Center in Atlanta, Georgia. , ...
(Date:2/4/2016)... and MENLO PARK, Calif. , Feb. ... ("DelMar" and the "Company"), a biopharmaceutical company focused on the ... it will present at the 18 th Annual ... 2016 at 10:00 a.m. EST in New York, ... president and CEO, will provide an update on the ongoing ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... China , today announced that the ... February 4, 2016 a preliminary non-binding proposal letter, dated ... V-Ming ( Shanghai ) Investment Holdings Co., ... Shenzhen ) Fund Management Co., Ltd., Beijing ...
Breaking Biology Technology:
(Date:1/20/2016)... SAN JOSE, Calif. , Jan. 20, 2016 ... leading developer of human interface solutions, today announced ... touch controller solution for wearables and small screen ... appliances such as printers. Supporting round and rectangular ... the S1423 offers excellent performance with moisture on ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
(Date:1/7/2016)... -- Various factors have contributed to the rise ... and biosimilars. Some of these factors include the ... for cost-effective alternatives, growing burden of chronic diseases, ... of their corresponding patented biologic drugs, and are ... efficacy. The global biosimilars market is estimated to ...
Breaking Biology News(10 mins):